Natco Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Natco Pharma has informed the stock exchanges that its trading window will remain closed starting April 1, 2026, until 48 hours after the company declares its financial results for the quarter and financial year ending March 31, 2026. The closure applies to directors, designated employees, their immediate relatives, and other connected persons as per the company's insider trading code under SEBI regulations. The exact date of the board meeting to announce the Q4 and FY26 results has not yet been disclosed and will be communicated later. This is a routine regulatory filing and does not contain any financial numbers or business updates.
No direct impact on shareholders or stock price. Investors should watch for the upcoming Q4 and FY26 earnings announcement, which is expected within the next few weeks.